Company Rayont Inc.

Equities

RAYT

US75508M1009

Biotechnology & Medical Research

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sector Other Biotechnology & Medical Research

Delayed OTC Markets Other stock markets 11:09:38 2024-04-30 am EDT			5-day change	1st Jan Change
0.1 ^USD	+19,900.00%		+19,900.00%	+1,000,000.00%

2023	Rayont Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023	CI
2023	Rayont Inc. Announces Board Appointments	CI

Rayont Inc. operates in the personalized natural healthcare sector in United States and Australia. The Company uses scientific tools, such as deoxyribonucleic acid (DNA), microbiome, iridology and other tests to diagnose and personalize the prescription of natural complementary medicine products, services and treatments to its patients in the markets the Company operate. The Company produces a range of products, including proteins, green blends, sports nutrition, weight management and maintenance, and health and wellness products. The Company's subsidiaries include Rayont (Malaysia) Sdn Bhd, Rayont International (L) Limited, Rayont (Australia) Pty Ltd and Prema Life (USA) Inc.

Number of employees: 58

USD in Million	2022	Weight	Delta
Nutritional Supplements and Myotherapy 100.0 %	3	100.0 %	-

USD in Million	2022	Weight	Delta
Australia 100.0 %	3	100.0 %	-

Managers	Title	Age	Since
Marshini Thulkanam CEO	Chief Executive Officer	48	20-03-30
Ilenna Copley COO	Chief Operating Officer	-	22-05-15
Dhurata Toli BRD	Director/Board Member	48	21-03-24
Paul Smith PRN	Corporate Officer/Principal	-	-

Members of the board	Title	Age	Since
Jason Sunstein BRD	Director/Board Member	52	22-04-20
Dhurata Toli BRD	Director/Board Member	48	21-03-24
Marshini Thulkanam CEO	Chief Executive Officer	48	20-03-30
Mark van Wyk BRD	Director/Board Member	-	22-04-20
Thea Dillon BRD	Director/Board Member	-	22-04-20
Bedri Thartori CHM	Chairman	-	23-02-22
Neelam Nadani Goundar BRD	Director/Board Member	-	23-02-22
Nara Chan BRD	Director/Board Member	-	23-02-22

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	50,163,797	24,169,968 ( 48.18 %)	0	48.18 %

Name	Equities	%	Valuation
Taleo Holdings Ltd. 41.47 %	20,803,079	41.47 %	624 092 $
Rural Asset Management Services, Inc. 8.436 %	4,232,000	8.436 %	126 960 $
Marshini Thulkanam 1.096 %	550,000	1.096 %	16 500 $
Dhurata Toli 0.3987 %	200,000	0.3987 %	6 000 $
Jason Sunstein 0.0125 %	6,250	0.0125 %	188 $
Mark van Wyk 0.004984 %	2,500	0.004984 %	75 $
Thea Dillon 0.004984 %	2,500	0.004984 %	75 $

Rayont, Inc.

228 Hamilton Avenue 3rd floor

94301, Palo Alto

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research

	1st Jan change	Capi.
RAYONT INC.	+1,000,000.00%	4.57M
MODERNA, INC.	+23.24%	48.09B
LONZA GROUP AG	+46.90%	40.62B
IQVIA HOLDINGS INC.	-3.01%	40.43B
CELLTRION, INC.	-6.20%	28.36B
ICON PUBLIC LIMITED COMPANY	+9.36%	24.89B
ALNYLAM PHARMACEUTICALS, INC.	-19.75%	19.01B
MEDPACE HOLDINGS, INC.	+29.51%	12.09B
BIO-TECHNE CORPORATION	+0.88%	11.88B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-1.09%	11.8B

Other Biotechnology & Medical Research